Zydus Lifesciences and Fortress Biotech subsidiaries announce positive data on CUTX-101in patients with Menkes disease : vimarsana.com

The data will be presented as a “Top-Rated Abstract” and Poster at the 2022 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting taking place March 22-26, 2022.

Related Keywords

, Music City Center , Zydus Lifesciences Ltd , Cyprium Therapeutics Inc , Drug Administration , Sentynl Therapeutics Inc , Zydus Group , Cadila Healthcare Ltd , Fortress Biotech Inc , American College Of Medical Genetics , Cyprium Therapeutics , Fortress Biotech , Sentynl Therapeutics , Zydus Lifesciences , Medical Genetics , Annual Clinical Genetics Meeting , Clinical Genetics , Chief Executive Officer ,